Timothy A. Morris
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Timothy A. Morris has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
Timothy M. Fernandes
Division of Pulmonary and Critical Care Medicine, University of California San Diego
3 shared publications- W. Cameron McGuire
Division of Pulmonary and Critical Care Medicine, University of California San Diego
3 shared publications Jina Chung
Division of Cardiology, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
2 shared publicationsKhadizhat Dakaeva
Division of Pulmonary and Critical Care Medicine, University of California San Diego
2 shared publicationsMona Alotaibi
Division of Pulmonary, Critical Care and Sleep Medicine, University of California, San Diego Healthcare, San Diego, USA
2 shared publicationsSavannah Aries
Division of Pulmonary and Critical Care Medicine, University of California San Diego
2 shared publications
Latest Publications
- Open Access
- 9 April 2026
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 68 (2) , 2501562
Chronic Thromboembolism Phenotypes after Acute Pulmonary Embolism: Identification with the SEARCH Algorithm
Rationale: Chronic dyspnea and exercise impairment are common after acute pulmonary embolism but poorly characterised. Objectives: We performed a prospective observational study to validate an algorithm to diagnose discrete post-pulmonary embolism outcomes, including chronic thromboembolism phenotypes. Methods: Six pulmonologists independently reviewed records from 150 consecutive patients three or more months after acute pulmonary embolism who had undergone a stepwise diagnostic algorithm (SEARCH): s ymptom screen, cardiopulmonary e xercise testing, pulmonary a rterial perfusion scans, r esting echocardiography, c onfirmatory imaging, and h emodynamic measurements by rest and exercise right heart catheterisation. Clinical data were reviewed after the first post-pulmonary embolism evaluation and then six months later. Measurements and Main Results: Symptomatic recovery was most common and occurred in 66.2% of patients during the final evaluation. Dyspnea without discernable physiological defects occurred in 2.1% and dyspnea from alternative diagnoses in 19.7%. Chronic thromboembolism phenotypes were diagnosed in 12.0% of patients. Chronic thromboembolism with ventilatory inefficiency and/or small stroke volume augmentation during exercise was seen in 6.3%: 2.1% without pulmonary hypertension on right heart catheterisation and 4.2% in whom right heart catheterisation was not performed. Chronic thromboembolic pulmonary hypertension and chronic thromboembolism with exercise-induced pulmonary hypertension occurred in 2.1% and 3.5%, respectively. Krippendorff's alpha among the readers was 0.984 (95% CI: 0.9663, 0.9960), signifying very high diagnostic reliability. No patient developed chronic thromboembolism between the first and final evaluations. Conclusions: Dyspnea from chronic thromboembolism is common after acute PE, most of which is not associated with pulmonary hypertension. The SEARCH protocol reliably identifies chronic thromboembolism phenotypes after acute embolism.
- 9 April 2026
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 68 (2) , 2501562
Open AccessChronic Thromboembolism Phenotypes after Acute Pulmonary Embolism: Identification with the SEARCH Algorithm
Rationale: Chronic dyspnea and exercise impairment are common after acute pulmonary embolism but poorly characterised. Objectives: We performed a prospective observational study to validate an algorithm to diagnose discrete post-pulmonary embolism outcomes, including chronic thromboembolism phenotypes. Methods: Six pulmonologists independently reviewed records from 150 consecutive patients three or more months after acute pulmonary embolism who had undergone a stepwise diagnostic algorithm (SEARCH): s ymptom screen, cardiopulmonary e xercise testing, pulmonary a rterial perfusion scans, r esting echocardiography, c onfirmatory imaging, and h emodynamic measurements by rest and exercise right heart catheterisation. Clinical data were reviewed after the first post-pulmonary embolism evaluation and then six months later. Measurements and Main Results: Symptomatic recovery was most common and occurred in 66.2% of patients during the final evaluation. Dyspnea without discernable physiological defects occurred in 2.1% and dyspnea from alternative diagnoses in 19.7%. Chronic thromboembolism phenotypes were diagnosed in 12.0% of patients. Chronic thromboembolism with ventilatory inefficiency and/or small stroke volume augmentation during exercise was seen in 6.3%: 2.1% without pulmonary hypertension on right heart catheterisation and 4.2% in whom right heart catheterisation was not performed. Chronic thromboembolic pulmonary hypertension and chronic thromboembolism with exercise-induced pulmonary hypertension occurred in 2.1% and 3.5%, respectively. Krippendorff's alpha among the readers was 0.984 (95% CI: 0.9663, 0.9960), signifying very high diagnostic reliability. No patient developed chronic thromboembolism between the first and final evaluations. Conclusions: Dyspnea from chronic thromboembolism is common after acute PE, most of which is not associated with pulmonary hypertension. The SEARCH protocol reliably identifies chronic thromboembolism phenotypes after acute embolism.
- Open Access
- 1 January 2026
- Published by Wiley in Pulmonary Circulation
- Vol. 16 (1)
Contrast Reflux Into IVC in Acute Pulmonary Embolism Predicts Clinical Deterioration Risk
Reflux of contrast medium into the inferior vena cava (IVC) on computed tomography pulmonary angiogram (CTPA) is an independent risk factor for mortality in patients with acute pulmonary embolism (PE). This study's aim was to determine if reflux into the IVC correlates with objective scores of clinical risk in acute PE. Patient‐level data were collected for adults diagnosed with acute PE by CTPA at University of California, San Diego Health between January 1 and June 30, 2023. Contrast reflux into the IVC was graded on a 4‐point scale. The primary endpoint was the correlation between reflux severity and risk for clinical deterioration as measured by the National Early Warning Score (NEWS). The secondary endpoint was interobserver reliability grading reflux amongst 16 reviewers. Fifty‐six subjects with acute PE were included. Extent of contrast reflux into the IVC correlated with NEWS ( Spearman's ρ 0.2932; p = 0.028). Subjects with grade 3 reflux had increased NEWS (7.80) compared to those with reflux grades 0 (3.63; p = 0.014) or 1 (4.29; p = 0.05). NEWS was elevated in those with contrast below the diaphragm compared to those without when grading was pooled ( p = 0.036). Interobserver reliability for reflux grading was “moderate” ( κ = 0.58), yet increased to “almost perfect” ( κ = 0.87) for pooled grading. Contrast reflux into the IVC during acute PE correlates with risk for clinical deterioration, as reflected by NEWS. Simplification of grading to contrast above or below the diaphragm improves reliability without compromising this relationship.
- 1 January 2026
- Published by Wiley in Pulmonary Circulation
- Vol. 16 (1)
Open AccessContrast Reflux Into IVC in Acute Pulmonary Embolism Predicts Clinical Deterioration Risk
Reflux of contrast medium into the inferior vena cava (IVC) on computed tomography pulmonary angiogram (CTPA) is an independent risk factor for mortality in patients with acute pulmonary embolism (PE). This study's aim was to determine if reflux into the IVC correlates with objective scores of clinical risk in acute PE. Patient‐level data were collected for adults diagnosed with acute PE by CTPA at University of California, San Diego Health between January 1 and June 30, 2023. Contrast reflux into the IVC was graded on a 4‐point scale. The primary endpoint was the correlation between reflux severity and risk for clinical deterioration as measured by the National Early Warning Score (NEWS). The secondary endpoint was interobserver reliability grading reflux amongst 16 reviewers. Fifty‐six subjects with acute PE were included. Extent of contrast reflux into the IVC correlated with NEWS ( Spearman's ρ 0.2932; p = 0.028). Subjects with grade 3 reflux had increased NEWS (7.80) compared to those with reflux grades 0 (3.63; p = 0.014) or 1 (4.29; p = 0.05). NEWS was elevated in those with contrast below the diaphragm compared to those without when grading was pooled ( p = 0.036). Interobserver reliability for reflux grading was “moderate” ( κ = 0.58), yet increased to “almost perfect” ( κ = 0.87) for pooled grading. Contrast reflux into the IVC during acute PE correlates with risk for clinical deterioration, as reflected by NEWS. Simplification of grading to contrast above or below the diaphragm improves reliability without compromising this relationship.
- Open Access
- 11 March 2024
- Published by Springer Nature in Respiratory Research
- Vol. 25 (1) , 1-10
Cardiopulmonary exercise test to detect cardiac dysfunction from pulmonary vascular disease
Background: Cardiac dysfunction from pulmonary vascular disease causes characteristic findings on cardiopulmonary exercise testing (CPET). We tested the accuracy of CPET for detecting inadequate stroke volume (SV) augmentation during exercise, a pivotal manifestation of cardiac limitation in patients with pulmonary vascular disease. Methods: We reviewed patients with suspected pulmonary vascular disease in whom CPET and right heart catheterization (RHC) measurements were taken at rest and at anaerobic threshold (AT). We correlated CPET-determined O2·pulseAT/O2·pulserest with RHC-determined SVAT/SVrest. We evaluated the sensitivity and specificity of O2·pulseAT/O2·pulserest to detect SVAT/SVrest below the lower limit of normal (LLN). For comparison, we performed similar analyses comparing echocardiographically-measured peak tricuspid regurgitant velocity (TRVpeak) with SVAT/SVrest. Results: From July 2018 through February 2023, 83 simultaneous RHC and CPET were performed. Thirty-six studies measured O2·pulse and SV at rest and at AT. O2·pulseAT/O2·pulserest correlated highly with SVAT/SVrest (r = 0.72, 95% CI 0.52, 0.85; p < 0.0001), whereas TRVpeak did not (r = -0.09, 95% CI -0.47, 0.33; p = 0.69). The AUROC to detect SVAT/SVrest below the LLN was significantly higher for O2·pulseAT/O2·pulserest (0.92, SE 0.04; p = 0.0002) than for TRVpeak (0.69, SE 0.10; p = 0.12). O2·pulseAT/O2·pulserest of less than 2.6 was 92.6% sensitive (95% CI 76.6%, 98.7%) and 66.7% specific (95% CI 35.2%, 87.9%) for deficient SVAT/SVrest. Conclusions: CPET detected deficient SV augmentation more accurately than echocardiography. CPET-determined O2·pulseAT/O2·pulserest may have a prominent role for noninvasive screening of patients at risk for pulmonary vascular disease, such as patients with persistent dyspnea after pulmonary embolism.
- 11 March 2024
- Published by Springer Nature in Respiratory Research
- Vol. 25 (1) , 1-10
Open AccessCardiopulmonary exercise test to detect cardiac dysfunction from pulmonary vascular disease
Background: Cardiac dysfunction from pulmonary vascular disease causes characteristic findings on cardiopulmonary exercise testing (CPET). We tested the accuracy of CPET for detecting inadequate stroke volume (SV) augmentation during exercise, a pivotal manifestation of cardiac limitation in patients with pulmonary vascular disease. Methods: We reviewed patients with suspected pulmonary vascular disease in whom CPET and right heart catheterization (RHC) measurements were taken at rest and at anaerobic threshold (AT). We correlated CPET-determined O2·pulseAT/O2·pulserest with RHC-determined SVAT/SVrest. We evaluated the sensitivity and specificity of O2·pulseAT/O2·pulserest to detect SVAT/SVrest below the lower limit of normal (LLN). For comparison, we performed similar analyses comparing echocardiographically-measured peak tricuspid regurgitant velocity (TRVpeak) with SVAT/SVrest. Results: From July 2018 through February 2023, 83 simultaneous RHC and CPET were performed. Thirty-six studies measured O2·pulse and SV at rest and at AT. O2·pulseAT/O2·pulserest correlated highly with SVAT/SVrest (r = 0.72, 95% CI 0.52, 0.85; p < 0.0001), whereas TRVpeak did not (r = -0.09, 95% CI -0.47, 0.33; p = 0.69). The AUROC to detect SVAT/SVrest below the LLN was significantly higher for O2·pulseAT/O2·pulserest (0.92, SE 0.04; p = 0.0002) than for TRVpeak (0.69, SE 0.10; p = 0.12). O2·pulseAT/O2·pulserest of less than 2.6 was 92.6% sensitive (95% CI 76.6%, 98.7%) and 66.7% specific (95% CI 35.2%, 87.9%) for deficient SVAT/SVrest. Conclusions: CPET detected deficient SV augmentation more accurately than echocardiography. CPET-determined O2·pulseAT/O2·pulserest may have a prominent role for noninvasive screening of patients at risk for pulmonary vascular disease, such as patients with persistent dyspnea after pulmonary embolism.
- Open Access
Observational cohort study to validate SEARCH, a novel hierarchical algorithm to define long-term outcomes after pulmonary embolism
Background Chronic dyspnoea and exercise impairment are common after acute pulmonary embolism (PE) but are not defined and quantified sufficiently to serve as outcomes in clinical trials. The planned project will clinically validate a novel method to determine discrete, clinically meaningful diagnoses after acute PE. The method uses an algorithm entitled SEARCH, for symptom screen, exercise testing, arterial perfusion, resting echocardiography, confirmatory imaging and haemodynamic measurements. SEARCH is a stepwise algorithm that sorts patients by a hierarchical series of dichotomous tests into discreet categories of long-term outcomes after PE: asymptomatic, post-PE deconditioning, symptoms from other causes, chronic thromboembolism with ventilatory inefficiency, chronic thromboembolism with small stroke volume augmentation, chronic thromboembolic disease and chronic thromboembolic pulmonary hypertension. Methods The project will test the inter-rater reliability of the SEARCH algorithm by determining whether it will yield concordant post-PE diagnoses when six independent reviewers review the same diagnostic data on 150 patients evaluated at two time points after PE. The project will also determine whether the post-PE diagnoses are stable, according to the SEARCH algorithm, between the first evaluation and the subsequent one 6 months later. Implications Validation of the SEARCH algorithm would offer clinicians a straightforward method to diagnose post-PE conditions that are rarely distinguished clinically. Their categorisation and definition will allow post-PE conditions to be used as endpoints in clinical trials of acute PE treatment. Trial registration number NCT05568927.
Open AccessObservational cohort study to validate SEARCH, a novel hierarchical algorithm to define long-term outcomes after pulmonary embolism
Background Chronic dyspnoea and exercise impairment are common after acute pulmonary embolism (PE) but are not defined and quantified sufficiently to serve as outcomes in clinical trials. The planned project will clinically validate a novel method to determine discrete, clinically meaningful diagnoses after acute PE. The method uses an algorithm entitled SEARCH, for symptom screen, exercise testing, arterial perfusion, resting echocardiography, confirmatory imaging and haemodynamic measurements. SEARCH is a stepwise algorithm that sorts patients by a hierarchical series of dichotomous tests into discreet categories of long-term outcomes after PE: asymptomatic, post-PE deconditioning, symptoms from other causes, chronic thromboembolism with ventilatory inefficiency, chronic thromboembolism with small stroke volume augmentation, chronic thromboembolic disease and chronic thromboembolic pulmonary hypertension. Methods The project will test the inter-rater reliability of the SEARCH algorithm by determining whether it will yield concordant post-PE diagnoses when six independent reviewers review the same diagnostic data on 150 patients evaluated at two time points after PE. The project will also determine whether the post-PE diagnoses are stable, according to the SEARCH algorithm, between the first evaluation and the subsequent one 6 months later. Implications Validation of the SEARCH algorithm would offer clinicians a straightforward method to diagnose post-PE conditions that are rarely distinguished clinically. Their categorisation and definition will allow post-PE conditions to be used as endpoints in clinical trials of acute PE treatment. Trial registration number NCT05568927.
- 13 July 2023
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 389 (2) , 184-187
Treatment of Intermediate-Risk Pulmonary Embolism
- 13 July 2023
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 389 (2) , 184-187
Treatment of Intermediate-Risk Pulmonary Embolism
- Open Access
- 23 March 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 61 (6) , 2300059
Cardiopulmonary exercise testing during follow-up after acute pulmonary embolism
Background: Cardiopulmonary exercise testing (CPET) may provide prognostically valuable information during follow-up after pulmonary embolism (PE). Our objective was to investigate the association of patterns and degree of exercise limitation, as assessed by CPET, with clinical, echocardiographic and laboratory abnormalities and quality of life (QoL) after PE.Methods: In a prospective cohort study of unselected consecutive all-comers with PE, survivors of the index acute event underwent 3- and 12-month follow-ups, including CPET. We defined cardiopulmonary limitation as ventilatory inefficiency or insufficient cardiocirculatory reserve. Deconditioning was defined as peak O2uptake (V′O2) <80% with no other abnormality.Results: Overall, 396 patients were included. At 3 months, prevalence of cardiopulmonary limitation and deconditioning was 50.1% (34.7% mild/moderate; 15.4% severe) and 12.1%, respectively; at 12 months, it was 44.8% (29.1% mild/moderate; 15.7% severe) and 14.9%, respectively. Cardiopulmonary limitation and its severity were associated with age (OR per decade 2.05, 95% CI 1.65–2.55), history of chronic lung disease (OR 2.72, 95% CI 1.06–6.97), smoking (OR 5.87, 95% CI 2.44–14.15) and intermediate- or high-risk acute PE (OR 4.36, 95% CI 1.92–9.94). Severe cardiopulmonary limitation at 3 months was associated with the prospectively defined, combined clinical-haemodynamic end-point of “post-PE impairment” (OR 6.40, 95% CI 2.35–18.45) and with poor disease-specific and generic health-related QoL.Conclusions: Abnormal exercise capacity of cardiopulmonary origin is frequent after PE, being associated with clinical and haemodynamic impairment as well as long-term QoL reduction. CPET can be considered for selected patients with persisting symptoms after acute PE to identify candidates for closer follow-up and possible therapeutic interventions.
- 23 March 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 61 (6) , 2300059
Open AccessCardiopulmonary exercise testing during follow-up after acute pulmonary embolism
Background: Cardiopulmonary exercise testing (CPET) may provide prognostically valuable information during follow-up after pulmonary embolism (PE). Our objective was to investigate the association of patterns and degree of exercise limitation, as assessed by CPET, with clinical, echocardiographic and laboratory abnormalities and quality of life (QoL) after PE.Methods: In a prospective cohort study of unselected consecutive all-comers with PE, survivors of the index acute event underwent 3- and 12-month follow-ups, including CPET. We defined cardiopulmonary limitation as ventilatory inefficiency or insufficient cardiocirculatory reserve. Deconditioning was defined as peak O2uptake (V′O2) <80% with no other abnormality.Results: Overall, 396 patients were included. At 3 months, prevalence of cardiopulmonary limitation and deconditioning was 50.1% (34.7% mild/moderate; 15.4% severe) and 12.1%, respectively; at 12 months, it was 44.8% (29.1% mild/moderate; 15.7% severe) and 14.9%, respectively. Cardiopulmonary limitation and its severity were associated with age (OR per decade 2.05, 95% CI 1.65–2.55), history of chronic lung disease (OR 2.72, 95% CI 1.06–6.97), smoking (OR 5.87, 95% CI 2.44–14.15) and intermediate- or high-risk acute PE (OR 4.36, 95% CI 1.92–9.94). Severe cardiopulmonary limitation at 3 months was associated with the prospectively defined, combined clinical-haemodynamic end-point of “post-PE impairment” (OR 6.40, 95% CI 2.35–18.45) and with poor disease-specific and generic health-related QoL.Conclusions: Abnormal exercise capacity of cardiopulmonary origin is frequent after PE, being associated with clinical and haemodynamic impairment as well as long-term QoL reduction. CPET can be considered for selected patients with persisting symptoms after acute PE to identify candidates for closer follow-up and possible therapeutic interventions.
- Open Access
- 12 January 2021
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 43 (1) , 105-107
Vacuum exhausted isolation locker (VEIL) to reduce inpatient droplet/aerosol transmission during COVID-19 pandemic
The vacuum-exhausted isolation locker (VEIL) provides a safety barrier during the care of COVID-19 patients. The VEIL is a 175-L enclosure with exhaust ports to continuously extract air through viral particle filters connected to hospital suction. Our experiments show that the VEIL contains and exhausts exhaled aerosols and droplets.
- 12 January 2021
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 43 (1) , 105-107
Open AccessVacuum exhausted isolation locker (VEIL) to reduce inpatient droplet/aerosol transmission during COVID-19 pandemic
The vacuum-exhausted isolation locker (VEIL) provides a safety barrier during the care of COVID-19 patients. The VEIL is a 175-L enclosure with exhaust ports to continuously extract air through viral particle filters connected to hospital suction. Our experiments show that the VEIL contains and exhausts exhaled aerosols and droplets.